(Q113887788)

English

Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

Intravitreal Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) (English)
0 references
0 references
16 May 2019
0 references
1 August 2021
0 references
100
0 references
18 year
0 references
70 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit